Dr. Stanley E. Waintraub, MD
- Medicare services, 2024
- 4,522
- Medicare patients, 2024
- 784
- Part D claims, 2024
- 1,530
- Publications
- 5
- Clinical trials
- 2
- Practice address
- 30 Prospect Ave, Hackensack, NJ 07601
- Practice phone
- Call (551) 996-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Waintraub's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Stanley E. Waintraub is a medical oncologist in Hackensack, New Jersey
Dr. Waintraub practices at Hackensack University Medical Center in Hackensack, New Jersey, part of Hackensack Meridian Health.
Dr. Waintraub's NPI, 1609835586, was assigned on March 21, 2006. Dr. Waintraub graduated from New York Medical College in 1977. Dr. Waintraub holds New Jersey license 25MA04179800.
- NPI
- 1609835586NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9335124148
- NPI enumeration date
- March 21, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (551) 996-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 75
- Medical school graduation
- 1977
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Stanley E. Waintraub practices at Hackensack University Medical Center in Hackensack, New Jersey
Dr. Waintraub's primary practice is Hackensack University Medical Center, at 30 Prospect Ave, Hackensack, NJ 07601 in Bergen County. The practice phone is (551) 996-2000.
- Hackensack University Medical Center30 Prospect Ave, Hackensack, NJ 07601 · Bergen CountyPhone(551) 996-2000
Source: Dmand AI Affiliation Data
Dr. Stanley E. Waintraub is affiliated with 5 sites of care and 2 medical groups
Dr. Waintraub's primary practice is Hackensack University Medical Center in Hackensack, New Jersey, part of Hackensack Meridian Health. Dr. Waintraub is also affiliated with Jersey Shore University Medical Center. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Dr. Waintraub to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Stanley E. Waintraub's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waintraub practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Hackensack University Medical Center | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Hackensack Meridian Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Stanley E. Waintraub is one of 115 medical oncologists in New Jersey
Medical oncology is Dr. Waintraub's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Waintraub is licensed in New Jersey.
Specialties and state licenses
- Medical oncology, New JerseyPrimary
Medical oncologists near Dr. Waintraub
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Stanley E. Waintraub billed Medicare for 4,522 services in 2024
CMS data shows 4,522 Medicare services from Dr. Waintraub across 9 procedure codes in 2024, for 784 Medicare patients. Medicare paid $327,478 for them.
Dr. Waintraub's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 8642024: 2,372175%
- Office and hospital visits
- 2023: 1,9712024: 2,0202%
- Tests and treatments
- 2023: 922024: 13041%
Where Dr. Waintraub's Medicare services took place, 2024
- In an office4,47699%
- In a facility461%
Dr. Waintraub compared with the New Jersey median for medical oncologists, 2024
- Dr. Waintraub
- New Jersey median
- Medicare services
- 4,522vs 7236.3 times
- Medicare patients
- 784vs 2323.4 times
- Part D claims
- 1,374vs 3593.8 times
Medians across 107 medical oncologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Waintraub's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Waintraub?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Waintraub and other medical oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Stanley E. Waintraub treated 784 Medicare patients in 2024, average age 74
CMS counts 784 Medicare patients who saw Dr. Waintraub in 2024. The largest group is 65 to 74, with 369 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Waintraub's median patient age at 62, with 92% women.
Dr. Waintraub's Medicare patients by age, 2024
Dr. Waintraub's Medicare patients by sex, 2024
- Women64582%
- Men13918%
Chronic conditions among Dr. Waintraub's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis47%
- Ischemic heart disease33%
- Diabetes32%
- Anxiety28%
- Mood disorders23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Waintraub's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 62
Patient panel by sex, all payers
- Women92%
- Men5%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Stanley E. Waintraub wrote 1,530 Medicare Part D claims in 2024
In 2024, Dr. Waintraub wrote 1,530 Medicare Part D claims for 406 patients. 82% of them were for generic drugs. CMS names the drug for 1,374 of them, across 15 drugs with 11 or more claims each, at $1,817,438 in total drug cost. In 2023, CMS named 1,299 claims across 18 drugs.
Dr. Waintraub's Part D claims by kind of drug, 2024
- Generic1,251 claims82%
- Brand-name and other279 claims18%
Dr. Waintraub's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,2992024: 1,3746%
Drugs named by CMS: 15 in 2024, 18 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Stanley E. Waintraub scored 87 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Waintraub for performance year 2024, reported individually. Dr. Waintraub accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Waintraub's MIPS scores, performance year 2024
- 87of 100Final score
- 55.2of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 89of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Stanley E. Waintraub has 5 publications on record
Dmand AI links 5 papers to Dr. Waintraub, published from 2016 to 2023. The most frequent topics are Breast Neoplasms and Receptor, ErbB-2. Dr. Waintraub's most frequent co-authors are Donna M. McNamara, MD, Stuart Leigh Goldberg, MD and Andre H. Goy, MD.
Dr. Waintraub's papers by year, 2016 to 2023
Topics Dr. Waintraub writes about most
- Breast Neoplasms
- Receptor, ErbB-2
Dr. Waintraub's most frequent co-authors
- Donna M. McNamara, MD3 shared papers
- Stuart Leigh Goldberg, MD2 shared papers
- Andre H. Goy, MD2 shared papers
Recent publications by Dr. Waintraub
Am J Manag Care
See who Dr. Waintraub researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Waintraub works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Stanley E. Waintraub has worked on 2 clinical trials
Dmand AI links Dr. Waintraub to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Male, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.
Conditions in Dr. Waintraub's trials
- Breast Neoplasms, Male
- Carcinoma, Intraductal, Noninfiltrating
- Breast Carcinoma In Situ
- Breast Neoplasms
Investigators on the most trials with Dr. Waintraub
- Bamidele A. Adesunloye, MD2 shared trials
- Mitchell B. Alden, DO2 shared trials
- Blair Ardman, MD2 shared trials
Recent clinical trials with Dr. Waintraub
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (opens in a new tab)
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Stanley E. Waintraub received $88,776 in industry payments from 2016 to 2025
CMS Open Payments shows 155 general payments to Dr. Waintraub from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 94% of the total. Amgen Inc. paid the most, $67,507.
General payments to Dr. Waintraub by program year, 2016 to 2025
General payments to Dr. Waintraub by kind, 2016 to 2025
- Speaker and faculty fees$83,15094%
- Food and beverage$2,6673%
- Travel and lodging$2,5893%
- Consulting fees$2500%
- Education$1200%
Companies that paid Dr. Waintraub the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Stanley E. Waintraub graduated from New York Medical College
Dr. Waintraub graduated from New York Medical College in 1977.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Stanley E. Waintraub's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Stanley E. Waintraub
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Stanley E. Waintraub's NPI number?
Dr. Stanley E. Waintraub's NPI number is 1609835586. It was assigned on March 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Stanley E. Waintraub?
Dr. Stanley E. Waintraub is a medical oncologist in Hackensack, New Jersey. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Stanley E. Waintraub practice?
Dr. Waintraub practices at 30 Prospect Ave, Hackensack, NJ 07601. Dr. Waintraub's primary practice is Hackensack University Medical Center in Hackensack, New Jersey, part of Hackensack Meridian Health. Dmand AI also links Dr. Waintraub to 1 hospital, 2 group practices and clinics and 1 medical group.
What is Dr. Stanley E. Waintraub's office phone number?
The practice phone on file for Dr. Waintraub is (551) 996-2000.
What is Dr. Stanley E. Waintraub's medical license number?
Dr. Waintraub holds New Jersey license 25MA04179800.
Which hospitals is Dr. Stanley E. Waintraub affiliated with?
Dr. Waintraub practices at Hackensack University Medical Center in Hackensack, New Jersey. Dr. Waintraub is also affiliated with Jersey Shore University Medical Center. Dmand AI links Dr. Waintraub to 1 more hospital.
What medical group is Dr. Stanley E. Waintraub part of?
Dr. Waintraub is linked to Regional Cancer Care Associates. Dmand AI links Dr. Waintraub to 1 more medical group.
Does Dr. Stanley E. Waintraub accept Medicare?
Yes. CMS data shows Dr. Waintraub billed Medicare for 4,522 services in 2024, and Dr. Waintraub accepts Medicare assignment.
What is Dr. Stanley E. Waintraub's MIPS score?
Dr. Waintraub's MIPS final score for performance year 2024 is 87 out of 100, reported individually.
How many Medicare patients does Dr. Stanley E. Waintraub see?
CMS counts 784 Medicare patients who saw Dr. Waintraub in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Stanley E. Waintraub bill to Medicare?
In 2024, Dr. Waintraub's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and medicare temporary code (Q5111).
Where did Dr. Stanley E. Waintraub go to medical school?
Dr. Waintraub graduated from New York Medical College in 1977.
What drugs does Dr. Stanley E. Waintraub prescribe most?
In 2024 Medicare Part D data, Dr. Waintraub's most prescribed drugs by claims were Anastrozole, Exemestane and Letrozole.
Has Dr. Stanley E. Waintraub received payments from drug or device companies?
CMS Open Payments shows $88,776 in general payments to Dr. Waintraub from 18 companies from 2016 to 2025. The largest total came from Amgen Inc.
How long has Dr. Stanley E. Waintraub been practicing?
Dr. Waintraub graduated from medical school in 1977, 49 years ago.
Does Dr. Stanley E. Waintraub do research?
Dmand AI links 5 publications to Dr. Waintraub, published from 2016 to 2023. Dr. Waintraub has worked on 2 clinical trials.
Who does Dr. Stanley E. Waintraub publish with?
Dr. Waintraub's most frequent co-authors are Donna M. McNamara, MD (3 shared papers), Stuart Leigh Goldberg, MD (2 shared papers) and Andre H. Goy, MD (2 shared papers).
Selling to medical oncology practices?
See medical oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card